New study finds that patients can likely switch between biosimilars of the same original biologic without any adverse effects or changes in how well their treatment works.
A new study found that white patients are more likely to be prescribed stronger doses of opioids than Black patients within the same health care system, which suggests race plays a role in how doctors manage patients’ pain relief.
By 
